Geode Capital Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-53,740
| Closed | -$732K | – | 5036 |
|
2021
Q4 | $732K | Buy |
53,740
+23,176
| +76% | +$316K | ﹤0.01% | 3857 |
|
2021
Q3 | $500K | Sell |
30,564
-10,193
| -25% | -$167K | ﹤0.01% | 4026 |
|
2021
Q2 | $685K | Sell |
40,757
-32,204
| -44% | -$541K | ﹤0.01% | 3789 |
|
2021
Q1 | $1.33M | Buy |
72,961
+38,258
| +110% | +$698K | ﹤0.01% | 3440 |
|
2020
Q4 | $631K | Sell |
34,703
-15,931
| -31% | -$290K | ﹤0.01% | 3516 |
|
2020
Q3 | $903K | Buy |
50,634
+1,892
| +4% | +$33.7K | ﹤0.01% | 3251 |
|
2020
Q2 | $873K | Buy |
48,742
+16,877
| +53% | +$302K | ﹤0.01% | 3185 |
|
2020
Q1 | $483K | Sell |
31,865
-31,109
| -49% | -$472K | ﹤0.01% | 3285 |
|
2019
Q4 | $1.24M | Buy |
62,974
+16,710
| +36% | +$330K | ﹤0.01% | 3203 |
|
2019
Q3 | $795K | Buy |
46,264
+8,238
| +22% | +$142K | ﹤0.01% | 3312 |
|
2019
Q2 | $673K | Sell |
38,026
-40,969
| -52% | -$725K | ﹤0.01% | 3357 |
|
2019
Q1 | $1.61M | Buy |
78,995
+31,672
| +67% | +$645K | ﹤0.01% | 2977 |
|
2018
Q4 | $795K | Buy |
+47,323
| New | +$795K | ﹤0.01% | 3200 |
|